A key treatment option for those who get mild to moderate COVID-19 symptoms is growing in use, health care professionals said during a media conference Friday.
The treatment is monoclonal antibodies infusion.
Basically, the therapy reduces the likelihood of a patient experiencing severe effects of COVID-19 that can place them in a hospital, perhaps on a ventilator or even death from complications of the virus, health care officials said.
Karen Ryan, her sister and her mother are close. They enjoy spending all their time together.
“The demand for monoclonal antibodies therapy has more than quadrupled in the last three weeks,” said Tami Minnier, UPMC chief quality officer. “We now have 45 sites able to perform the treatment.”
The three larger health care systems in and near Somerset County — UPMC